Comparative Evaluation of Herbal and Allopathic Drugs for the Treatment of Chronic Diarrhea
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
Revival of significance and the emergent market of herbal medicinal products necessitate
strong commitment by the stakeholders to safeguard the end users. The variability in the
concentrations of constituents of plant material, coupled with the variety of extraction
techniques and processing steps used by different manufacturers, results in distinct
inconsistency in the quality of herbal products. The present study will be directed to a
polyherbal formulation Entoban which integrates an outstanding blend of herbs that have been
used for decades to eradicate microorganisms and worms from gastrointestinal tract. It is the
combination of Holarrhena antidysenterica, Berberis aristata, Symplocos racemosa, Querecus
infectoria and Helicteres isora. The current study would target the chemical assessment,
pharmacological and comparative clinical evaluation of Entoban to assure its safety and
efficacy.